Skip to main content
Logo
European Innovation Council
  • private sector

XENOTHERA

 Treat severe cases of infection at COV with XAV-19

XENOTHERA Logo

Overview

Description

Developer of immunosuppressants designed for transplantation and other indications. The company developed a Glyco-humanized antibody platform with embedded technology for the creation of hyperimmune polyclonal sera, enabling the medical community to optimize immunological treatments

Website
Country
  • France
Sector
  • Health Biotechnology